However, it may contribute to more aggressive cancer progression over time due to the metabolic conditions that it induces, such as chronic inflammation, insulin resistance, hyperglycemia, hormonal imbalance, and leptin and adipokine dysregulation [33,34]. This evidence concerns the gene LEP and cancer.